104 related articles for article (PubMed ID: 22873502)
1. Hypocalcemia induced by raloxifene.
Vu TD; Varadarajan S; Seeman E; Jerums G; MacIsaac RJ
Curr Drug Saf; 2012 Apr; 7(2):176-8. PubMed ID: 22873502
[TBL] [Abstract][Full Text] [Related]
2. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
Nagatoya K; Nishimoto K; Shibahara N; Takahashi T; Kanehara H; Ueno N; Yasuda H; Okada S; Ueda H; Hirai K; Inoue T;
Clin Exp Nephrol; 2015 Oct; 19(5):939-46. PubMed ID: 25504368
[TBL] [Abstract][Full Text] [Related]
3. Re: Raloxifene and stroke risks in Japanese postmenopausal women with osteoporosis on postmarketing surveillance.
Hamaya E; Sowa H
Menopause; 2014 Jan; 21(1):109-10. PubMed ID: 24281238
[No Abstract] [Full Text] [Related]
4. Safety of 3-year raloxifene treatment in Japanese postmenopausal women aged 75 years or older with osteoporosis: a postmarketing surveillance study.
Takeuchi Y; Hamaya E; Taketsuna M; Sowa H
Menopause; 2015 Oct; 22(10):1134-7. PubMed ID: 25756692
[TBL] [Abstract][Full Text] [Related]
5. Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women.
Gorai I; Tanaka Y; Hattori S; Iwaoki Y
J Bone Miner Metab; 2010 Mar; 28(2):176-84. PubMed ID: 19657590
[TBL] [Abstract][Full Text] [Related]
6. Severe Hypocalcemia Following a Single Denosumab Injection.
Cernes R; Barnea Z; Biro A; Zandman-Goddard G; Katzir Z
Isr Med Assoc J; 2017 Nov; 19(11):719-721. PubMed ID: 29185289
[No Abstract] [Full Text] [Related]
7. In reply.
Urushihara H
Menopause; 2014 Jan; 21(1):110. PubMed ID: 24326283
[No Abstract] [Full Text] [Related]
8. Quality of life in Japanese women with postmenopausal osteoporosis treated with raloxifene and vitamin D: post hoc analysis of a postmarketing study.
Ohta H; Hamaya E; Taketsuna M; Sowa H
Curr Med Res Opin; 2015 Jan; 31(1):85-94. PubMed ID: 25299349
[TBL] [Abstract][Full Text] [Related]
9. Mandibular Osteonecrosis Associated With Raloxifene.
Pontes HAR; Souza LL; Uchôa DCC; Cerqueira JMM
J Craniofac Surg; 2018 May; 29(3):e257-e259. PubMed ID: 29303860
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).
Fujiwara S; Hamaya E; Sato M; Graham-Clarke P; Flynn JA; Burge R
Clin Interv Aging; 2014; 9():1879-93. PubMed ID: 25395843
[TBL] [Abstract][Full Text] [Related]
11. Raloxifene vs tamoxifen.
Goldstein SR
JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
[No Abstract] [Full Text] [Related]
12. Does raloxifene therapy affect mammographic breast cancer screening in postmenopausal patients?
Cirpan T; Akercan F; Itil IM; Gundem G; Bilgen I; Yucebilgin MS
Eur J Gynaecol Oncol; 2006; 27(2):177-8. PubMed ID: 16620065
[TBL] [Abstract][Full Text] [Related]
13. Activated vitamin D3 formulations can be safely used as concomitant medication for prevention of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis.
Saito S; Sugo Y; Tsuburai T; Kurasawa K; Nakamura T; Yoshikata H; Miyagi E; Sakakibara H
J Obstet Gynaecol Res; 2019 Apr; 45(4):908-914. PubMed ID: 30618176
[TBL] [Abstract][Full Text] [Related]
14. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis.
Cranney A; Adachi JD
Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus in women can be RUTHless: lessons from the Raloxifene Use for The Heart (RUTH) Trial.
Budoff MJ
Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):137-8. PubMed ID: 23481520
[No Abstract] [Full Text] [Related]
16. Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis.
Majima T; Shimatsu A; Komatsu Y; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K
Endocr J; 2008 Mar; 55(1):41-8. PubMed ID: 18187874
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene ameliorates progressive bone loss in postmenopausal dialysis patients with controlled parathyroid hormone levels.
Eriguchi R; Umakoshi J; Miura S; Sato Y
Clin Nephrol; 2009 Dec; 72(6):423-9. PubMed ID: 19954718
[TBL] [Abstract][Full Text] [Related]
18. Carotid artery intima-media thickness after raloxifene treatment.
Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
[TBL] [Abstract][Full Text] [Related]
19. Role of vitamin K2 in the treatment of postmenopausal osteoporosis.
Iwamoto J; Takeda T; Sato Y
Curr Drug Saf; 2006 Jan; 1(1):87-97. PubMed ID: 18690918
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis.
Lu HF; Chou PH; Lin GH; Chou WH; Wang ST; Adikusuma W; Mugiyanto E; Hung KS; Chang WC
Dis Markers; 2020; 2020():8855423. PubMed ID: 32934756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
